Late complications of chemotherapy in testicular cancer

被引:22
|
作者
Pliarchopoulou, Kyriaki [1 ]
Pectasides, Dimitrios [1 ]
机构
[1] Univ Athens, Dept Internal Med 2, Propaedeut Oncol Sect, Attikon Univ Hosp, Athens, Greece
关键词
Germ-cell tumors; Toxicity; Long-term survivors; GERM-CELL TUMORS; LONG-TERM SURVIVORS; CORONARY-ARTERY DISEASE; COMBINATION CHEMOTHERAPY; RENAL-FUNCTION; RAYNAUDS-PHENOMENON; SECONDARY LEUKEMIA; FOLLOW-UP; 2ND CANCERS; CARDIOVASCULAR RISK;
D O I
10.1016/j.ctrv.2009.12.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cisplatin-based treatment has significantly increased survival in testicular cancer patients. Therefore, there has been enough interest for the late toxic effects of chemotherapy which affect the quality of life of the cancer survivors. These toxic effects may either persist or present long after the end of chemotherapy and involve the impairment of renal function, neurotoxicity, pulmonary toxicity and vascular disease. Also, a major issue experienced by a large number of patients is infertility, which has been improved due to modified surgical techniques, reduced treatment intensity, the use of sperm cryopreservation and methods of assisted reproduction. Physicians should also be aware of the risk of secondary malignancy development. Therefore, close follow-up of the testicular cancer survivors as well as, focus on minimizing treatment complications through improvement of treatment strategies are warranted. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:262 / 267
页数:6
相关论文
共 50 条
  • [21] INTENSIVE CHEMOTHERAPY IN TESTICULAR CANCER
    BIRON, P
    PATHOLOGIE BIOLOGIE, 1994, 42 (10): : 996 - 996
  • [22] TESTICULAR CANCER AND THE LEGACY OF CHEMOTHERAPY
    MUGGIA, FM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (01) : 1 - 5
  • [23] CHEMOTHERAPY FOR ADVANCED TESTICULAR CANCER
    FOX, EP
    LOEHRER, PJ
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1991, 5 (06) : 1173 - 1187
  • [24] CHEMOTHERAPY OF DISSEMINATED TESTICULAR CANCER
    WILLIAMS, SD
    EINHORN, LH
    ARIZONA MEDICINE, 1978, 35 (09) : 595 - 597
  • [25] CHEMOTHERAPY OF DISSEMINATED TESTICULAR CANCER
    EINHORN, LH
    WILLIAMS, SD
    WESTERN JOURNAL OF MEDICINE, 1979, 131 (01): : 1 - 3
  • [26] ADJUVANT CHEMOTHERAPY FOR TESTICULAR CANCER
    LOGOTHETIS, CJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (01): : 53 - 53
  • [27] LATE RELAPSE OF TESTICULAR CANCER
    BANIEL, J
    FOSTER, RS
    GONIN, R
    MESSEMER, JE
    DONOHUE, JP
    EINHORN, LH
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) : 1170 - 1176
  • [28] LATE RELAPSE OF TESTICULAR CANCER
    TEREBELO, HR
    TAYLOR, HG
    BROWN, A
    MARTIN, N
    STUTZ, FH
    BLOM, J
    GEIER, L
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (09) : 566 - 571
  • [29] LATE RECURRENCE OF TESTICULAR CANCER
    BORGE, N
    FOSSA, SD
    OUS, S
    STENWIG, AE
    LIEN, HH
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) : 1248 - 1253
  • [30] Late relapse of testicular cancer
    Albers, P
    Lipphardt, M
    Mueller, SC
    JOURNAL OF UROLOGY, 2003, 169 (04): : 176 - 176